Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
29%(2 trials)

Phase Distribution

Ph not_applicable
5
50%
Ph phase_2
1
10%
Ph phase_4
3
30%
Ph phase_3
1
10%

Phase Distribution

0

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
1(10.0%)
Phase 3Large-scale testing
1(10.0%)
Phase 4Post-market surveillance
3(30.0%)
N/ANon-phased studies
5(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(7)
Other(3)

Detailed Status

Completed7
unknown3

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (10.0%)
Phase 31 (10.0%)
Phase 43 (30.0%)
N/A5 (50.0%)

Trials by Status

unknown330%
completed770%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10